What if bleeding after childbirth was no longer the world leading cause of maternal death?

Learn more

Did you know

14M

Postpartum hemorrhage cases each year.

Heart

25%

Most important cause of maternal deaths.

Heart

$522-1,183

Estimated cost per unit of blood transfused

Heart

“… The mother didn´t understand why suddenly a person was sitting on top of her, squeezing down on her belly. The midwife had to roar at her to accept the manoeuvre, although it was painful.“

- Swedish Midwife

“No woman should fear for her life when giving birth. Effective solutions to tackle postpartum bleeding need to be available and accessible so that all women can experience a safe birth and a healthy future with their families.“

“The management of postpartum hemorrhage, particularly in severe cases, requires significant healthcare resources including blood transfusions, surgical interventions, and extended hospital stays.“

“Time is of the essence when responding to postpartum bleeding, so interventions that eliminate delays in diagnosis or treatment should be gamechangers for maternal health.“

AAuniversaluniversalsolutionsolutiontotominimizeminimizebloodbloodlosslossininpostpartumpostpartumhemorrhagehemorrhage

product animation

Discover EMMA by Zerocyte

The Emergency Maternal Bleeding Stabilizer is designed to replace and enhance the manual procedure of aortic compression and is specifically engineered to align with postpartum physiology.

Learn more

Immediate Response: The fastest and easiest way to limit blood loss, preventing massive bleeding events and life-threatening complications.

Versatility: Effective in all causes of postpartum hemorrhage, designed to complement standard procedures and treatments.

Consistency and Precision: Mitigates variations in human performance and fatigue, ensuring effective bleeding control every time and in complicated situations like patient transportation and perioperative procedures.

Crew Resource Management: Replacing the need for continuous manual intervention allowing key team members to attend to other tasks, optimizing resource allocation in busy clinical settings.

Health Economy: Designed for multiple uses and to reduce the need for expensive interventions, making it a cost-effective investment.

Environmentally Friendly: Reduces medical waste and transportation of single use products, supporting net-zero goals.

Emma bow

How it works

Reliable Aortic Compression

External compression of the distal abdominal aorta significantly reduces uterine blood flow while maintaining central blood pressure and perfusion of vital organs.

Zero maternal deaths

One Solution - Global Reach

Our vision is to make EMMA bleeding stabilizer accessible to every woman worldwide transforming massive postpartum hemorrhage into a ghost of the past.

Roadmap

Zerocyte Timeline

A brief overview of our past achievements.

Achievements

  • Founding team formation

  • Initial funding secured

    Raised initial pre-seed grants to support early development stages.

  • Established Product Development Contract

    Secured a comprehensive contract with an esteemed industrial partner for complete product development including quality assurance system and regulatory compliance.

  • Initial Concept and Prototype Development

    Developed and tested a working prototype of EMMA, demonstrating proof of concept.

  • Regulatory strategy established

  • Initial usability testing

    Conducted successful preclinical testing in a regional hospital in Sweden to gain early user insights on design, usability and safety.

  • Intellectual property secured

    Patent application for core traits of the EMMA device filed.

  • Market Research

    Conducted survey regarding user insights and today’s management of postpartum hemorrhage and attitudes towards compressive measures.

News & Events

Karolinska Institutet Holding
News

November 2024

Karolinska Institutet Holding

We are pleased to welcome our new partner KI Holding. We believe that developing our company together with strategic investors that share our vision, builds a strong foundation and enables long term success.

Karolinska Institutet Innovations
News

October 2024

Karolinska Institutet Innovations

We are proud to announce that we are now part of the KI Innovations business incubator DRIVE together with other exciting life science start-ups.

Nordic Life Science days
Event

September 18-19, 2024

Nordic Life Science days

In september we attended Nordic Life Science Days with our Innovation Poster. It was really inspiring to meet so many brilliant people in the forefront of health care with exciting new solutions to major global health issues.

Malmö, Sweden

Contact Us

Get in Touch

We are always looking for new opportunities and partnerships.

Good to know

Frequently Asked Questions

We’ve compiled answers to frequently asked questions to help you better understand our technology and its benefits for maternal care. In the 'Join Our Mission' FAQ section, you'll also find information about our business model and current investment opportunities.